Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Stable quarter with good profitability

"We leave behind us a stable quarter, with sales growth in all operating segments together with continued good profitability. The Group's total sales amounted to SEK 9,493 million, corresponding to a growth of 12 per cent. EBITA amounted to SEK 1,084 million, corresponding to an increase of 13 per cent, and the EBITA margin was 11.4 per cent (11.3). Organic sales increased by 3 per cent during the period. A good operating cash flow of SEK 1,231 million continues to support expansionary possibilities in the market," says CEO Christopher Norbye. Webcast and Telephone conference Q3 2024

Interim Report Q3: 1 Jan–30 Sept 2024

Continued weak market – several initiatives for the futureThird quarter highlights · Revenue increased by 1.0 per cent to MSEK 2,143 (2,122). Organic growth was -3.0 per cent. · Gross margin was 40.5 per cent (41.6). · Adjusted EBITA decreased to MSEK 137 (191), corresponding to an adjusted EBITA margin of 6.4 per cent (9.0). · Operating profit decreased to MSEK 115 (175) and the operating margin was 5.4 per cent (8.2). Operating profit was charged with items affecting comparability of MSEK -6 (0). · Profit amounted to MSEK 60 (113). · Earnings per share amounted to SEK

Attendo’s third quarter report 2024: IMPROVEMENT IN PERFORMANCE AND CUSTOMER SATISFACTION

Attendo continues to report good growth in both sales and profit in the third quarter of 2024. In Scandinavia, sales and profit increased mainly as a result of the acquisition of Team Olivia and continued good development in own nursing homes. In Finland, sales are also increasing and profit improved compared with the third quarter of 2023. Attendo also noted a clear increase in customer satisfaction in national user surveys in both Sweden and Finland.Comments from Martin Tivéus, Attendo president and CEO “We continue to show good growth in both sales and earnings in the third quarter.

Notice of Annual General Meeting of AcadeMedia AB (publ)

The shareholders of AcadeMedia AB (publ), reg, no. 556846-0231, with its registered office in Stockholm, are summoned to the Annual General Meeting on Thursday 28 November 2024 at 2 p.m. at AcadeMedia’s head office, Adolf Fredriks Kyrkogata 2, Stockholm. Registration starts at 1 p.m.   Timeline: Record Date                                                               20 November 2024 Last day to notify attendance                                                22 November 2024 Last day to re-register nominee-registered shares                          22 November 2024 Date of

AcadeMedia’s interim report, July 2024 – September 2024

First quarter (July – September 2024) · Net sales increased by 12,0 percent and amounted to SEK 3,842 million (3,430). Organic growth, including bolt-on acquisitions, was 6.0 percent. · Operating profit (EBIT) amounted to SEK 272 million (232). · Adjusted operating profit, adjusted for items affecting comparability and effects of IFRS 16, amounted to SEK 157 million (151). There were no items affecting comparability in the quarter (SEK -6 million). · Net profit for the period amounted to SEK 80 million (62). · Earnings per share was SEK 0.79 (0.59) after dilution. Adjusted

Lifetime Achievement Award, lecanemab and biomarkers in focus at CTAD

Stockholm, October 24, 2024 – BioArctic AB’s (publ) (Nasdaq Stockholm: BIOA B) founder Lars Lannfelt will be presented with the Lifetime Achievement Award in Alzheimer's Disease Therapeutic Research at the Clinical Trials for Alzheimer's Disease Conference (CTAD) held in Madrid, Spain, and virtually from October 29 to November 1. Lars Lannfelt will be one of the keynote speakers at the conference. In addition, BioArctic’s partner Eisai present lecanemab data in two oral and one poster presentation at the meeting and three symposia will focus on lecanemab. Data shared will include the

News conference on Kojamo’s Interim Report for January–September 2024 on 7 November 2024

Kojamo plc Press Release, 24 October 2024 at 9:00 a.m. EESTNews conference on Kojamo’s Interim Report for January–September 2024 on 7 November 2024 Kojamo plc’s Interim Report for January–September 2024 will be published on Thursday, 7 November 2024 at approximately 8:00 a.m. EET. News conference and webcast Kojamo will hold a news conference for institutional investors, analysts and media on 7 November 2024 at 10:00 a.m. EET at its headquarters at Mannerheimintie 168A, Helsinki, Finland. The event will be hosted by Kojamo’s Interim CEO Erik Hjelt, and it will be held in English.

Careiums AB’s Nomination Committee for the 2025 Annual General Meeting

In accordance with the decision by Careium AB’s Annual General Meeting (AGM) on April 25, 2024, the chairman of the board, Maria Khorsand, has summoned the Nomination Committee.After consultation with the major shareholders of the company as per 30 September 2024, the committee consists of the following members: · Peter Lindell, Cidro Capital Förvaltning, appointed commitee Chairman, · Mark Shay, Accendo Capital · Richard Torgerson, Nordea Funds · Maria Khorsand, Chairman of the Board, adjunct member of the Nomination Committee The Nomination Committee will prepare

AcadeMedia publishes the Annual and Sustainability report for 2023/2024

AcadeMedia’s 2023/2024 Annual Report is now available on the corporate website, and as an attached pdf to this press release. The Sustainability report is located on pages 15-47.https://academedia.se/en/about-us/investors/reports-and-presentations/ With consideration to the environment, this Annual and Sustainability report is only published digitally. For more information, please contact:Hanna Clausén, IRTelephone: +46 70 587 97 67E-mail: hanna.clausen@academedia.se About AcadeMedia AcadeMedia creates opportunities for people to develop. The 21,000 employees at our 860

OKEA third quarter 2024 trading update

(Trondheim, 24 October 2024) OKEA ASA (OSE: OKEA) will publish its financial report for the third quarter of 2024 on Thursday 31 October at 06:00 (CEST). This trading update is provided to summarise production and sales volumes and related updates for the quarter.Third quarter 2024 production and sales   Unit Q3 2024 Q2 2024Total operating income MNOK 2,926 2,584Realised liquids price USD/boe 74.9 79.7Realised gas price USD/boe 68.9 65.7Net production

Sobi Q3 2024 report: Strong growth and significant pipeline momentum

Swedish Orphan Biovitrum AB (publ) (Sobi®) today announced its report for the third quarter 2024Third Quarter 2024 •         Total revenue increased 33 per cent, 39 per cent at constant exchange rates, (CER)1, to SEK 6,894 M (5,168) •         Haematology revenue increased 18 per cent at CER to SEK 4,000 M (3,484), mainly driven by strong sales of Doptelet[®] of SEK 1,039 M (650), sales of Aspaveli[®]/Empaveli[®] of SEK 270 M (169) and launch sales of Altuvoct[®] of SEK 129 M (—)  •         Immunology revenue increased 96 per cent at CER to SEK 2,583 M (1,400), driven by strong

Fractal Gaming Group Interim Report January-September 2024

Third quarter 2024•    Net sales amounted to SEK 156.6 million (189.9).•    Product profit amounted to SEK 59.1 million (79.3), with a product margin of 37.8% (41.8).•    EBITDA amounted to SEK 11.6 million (35.1), corresponding to an EBITDA margin of 7.4% (18.5).•    EBIT amounted to SEK 5.7 million (29.8), corresponding to an EBIT margin of 3.6% (15.7).•    Operating cash flow amounted to SEK 14.8 million (65.0).•    Interest-bearing net debt was SEK -29.8 million (-75.5).•    Earnings per share amounted to SEK 0.0 (0.8).•    No items affecting comparability for the

Metsä Board renews its dividend policy

Metsä Board Corporation  Stock exchange release  Other information disclosed according to the rules of the Exchange  24 October 2024 at 9.00 a.m. EETMetsä Board Corporation's (“Metsä Board”) Board of Directors has decided to renew the company's dividend policy. The new dividend policy supports Metsä Board's strategy to grow in fibre-based packaging materials and renew its industrial operations. The new dividend policy is: Metsä Board's target is to distribute a dividend of at least half of the result for the financial period over time, taking into account the company's future investment

Interim report Q3, 2024: Improved growth with solid margins

Third quarter · Sales of SEK 867 (848) million, an increase of 7% in local currencies and 2% in SEK. · Sales per region, in local currencies was +9% in EMEA, +2% in Americas and +9% in APAC. · Sales per business area, in local currencies was +13% in Consumables, +11% in Technologies and 0% in Genetics. · Gross margin increased to 58.6% (55.7). · Operating income before depreciation and amortisation (EBITDA) was SEK 289 (287) million, giving an EBITDA margin of 33.4% (33.9). · Operating cash flow decreased to SEK 206 million (214). · Net income was SEK 116 (122)

Interim Report January - September 2024

· Income amounted to SEK 2,780 million (3,228) · Operating surplus amounted to SEK 1,808 million (2,250) · Net financial income amounted to SEK –950 million (–1,098) · Profit from property management amounted to SEK 736 million (1,016) · Changes in value of properties amounted to –473 million (–5,823) during the period and SEK 12 million (–2,912) during the quarter · Profit/loss for the period amounted to SEK –268 million (–4,934), corresponding to SEK –0.62 (–4.91) per ordinary share of class A and B · Net letting amounted to SEK 99 million during the period (90) · The

Interim information January–September 2024

This interim information for the period January-September 2024 has been prepared for the purpose of complying with the terms of Corem Kelly AB’s (publ) bond and loan agreements.   JANUARY–SEPTEMBER 2024   · Income amounted to SEK 2,458 million (2,695) · Profit from property management amounted to SEK 741 million (1,003) · Profit before tax amounted to SEK 114 million (–5,201)   EVENTS DURING THE THIRD QUARTER · Bonds of SEK 436 million, with maturity in February 2025, were repurchased during the quarter. · Hybrid bonds of SEK 148 million were repurchased

Corem signs five-year lease with Mycronic for approximately 6,000 sq.m. in Kista

Corem has signed a five-year lease agreement with the Swedish technology company Mycronic for 6,038 square meters in the property Helgafjäll 5 in Kista north of Stockholm city. The property is located in central Kista by the square next to the Kista fair. Mycronic, which has its operations in Täby, north of Stockholm, now also sets up operations in Kista as they relocate their High Flex division to the area. The new premises, which will house offices, warehouses and production, are adapted to support the business. At the same time, the building gets an exterior lift. Access is

Sleep Cycle Interim Report July – September 2024: Strong Third Quarter with Solid Margins

Gothenburg, Sweden – 24 oktober, 2024The third quarter in summary (July-September 2024) · Net sales totaled tSEK 65 873 (60 777) and increased by 8.4% (11,2%). Currency-adjusted net sales growth amounted to 9,9% (2,7%). · Operating profit amounted to tSEK 20 612 (20 271), with an operating margin of 31.3% (33.4%) · The total number of paying subscribers at end of the period was 915k (887k). · ARPU in the quarter amounted to SEK 280 (275) kr. Currency adjusted ARPU was SEK 284. · Earnings per share before and after dilution for the quarter amounted to SEK 0,82 (0,81).

Tietoevry's Interim Report 3/2024: Improved profitability – growth impacted by weakening market

Tietoevry Corporation INTERIM REPORT   24 October 2024, 9:00 a.m. (EEST)   · Revenue decrease of 1% – growth impacted by the weakening market · Resilient profitability of 13.5% · Strategic review of Tietoevry Tech Services progressing – the company is in an exclusive process with a non-industrial buyer     The full interim report with tables is available at the end of this release.     7–9/2024 7–9/2023 1–9/2024 1–9/2023Revenue, EUR million  655.0  659.7  2 103.9  2 099.2     Organic growth1), %  -1  2  -1

Orexo Interim Report Q3 2024

Q3 2024 highlights ›  Total net revenues of SEK 136.5 m (156.1) ›  EBITDA of SEK -0.7 m (-9.5) ›  Net earnings of SEK -41.9 m (-33.3) ›  US Commercial segment net revenues of SEK 131.0 m (140.4), in local currency USD 12.6 m (13.0) ›  Cash flow from operating activities of SEK -13.4 m (-21.9), cash and cash equivalents of SEK 114.9 m (184.2) ›  Earnings per share before and after dilution amounted to SEK -1.21 (-0.97) ›  Orexo AB´s sustainability work ranked among the top five percent of all 70,000 businesses worldwide reviewed by EcoVadis ›   For OX124, our high

Everysport Group publishes Interim Report for Q3 2024: Elite Prospects drives progress towards profitable growth

Summary Q3 2024 (compared to Q3 2023)  · The Group's net sales amounted to SEK 19.1 million (36.5). Excluding divested operations, net sales increased by 1 percent to SEK 19.1 million (18.9). · Business area Elite Prospect: · Net sales increased by 23 percent to SEK 10.5 million (8.5). · Monthly recurring subscription revenue (MRR) increased by 11 percent to SEK 2.4 million (2.1). · Annual recurring subscription revenue (ARR) calculated as of the end of September increased by 20 percent to SEK 28.8 million (24.0). · The Everysport business area's net sales

There are no items matching the current filter
There are no more items matching the current filter
Back to top